Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dai Hoon Han

Showing results (71-80 of 121) with videos related to

Pageof 13
Sort By:
Yonsei Medical Journal|July 13, 2016
Living Donor Liver Transplantation for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis after Concurrent Chemoradiation TherapyDai Hoon Han, Dong Jin Joo, Myoung Soo Kim, et al.
Hepatobiliary Surgery and Nutrition|December 12, 2025
Anatomical complexity of the right-lobe grafts: influence on the outcomes in living donor liver transplantationSeung Hyuk Yim, Incheon Kang, Deok-Gie Kim, et al.
Autophagy|January 9, 2020
SQSTM1/p62 activates NFE2L2/NRF2 via ULK1-mediated autophagic KEAP1 degradation and protects mouse liver from lipotoxicityDa Hyun Lee, Jeong Su Park, Yu Seol Lee, et al.
Journal of Hepatology|May 4, 2020
A nomogram based on liver stiffness predicts postoperative complications in patients with hepatocellular carcinomaMatteo Serenari, Kwang-Hyub Han, Federico Ravaioli, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 3, 2020
Liver-directed combined radiotherapy as a bridge to curative surgery in locally advanced hepatocellular carcinoma beyond the Milan criteriaWon Hee Lee, Hwa Kyung Byun, Jin Sub Choi, et al.
Cancers|November 21, 2020
Hepatocellular Carcinoma Risk According to Regimens for Eradication of Hepatitis C Virus; Interferon or Direct Acting AntiviralsHye Won Lee, Dai Hoon Han, Hye Jung Shin, et al.
Journal of Gastroenterology and Hepatology|March 23, 2013
Prognostic significance of the worst grade in hepatocellular carcinoma with heterogeneous histologic grades of differentiationDai Hoon Han, Gi Hong Choi, Kyung Sik Kim, et al.
Clinical Colorectal Cancer|June 4, 2023
Effect of High-Versus Low-Frequency of Abdominopelvic Computed Tomography Follow-Up Testing on Overall Survival in Patients With Stage II Or III Colon CancerJeongseok Jeon, Da Bin Lee, Sang Joon Shin, et al.
Journal of Hepatology|January 20, 2025
Genomic and transcriptomic signatures of sequential carcinogenesis from papillary neoplasm to biliary tract cancerTaek Chung, Seungho Oh, Jeongsoo Won, et al.
Clinical and Molecular Hepatology|July 23, 2021
Impact of everolimus on survival after liver transplantation for hepatocellular carcinomaIncheon Kang, Jae Geun Lee, Sung Hoon Choi, et al.
Pageof 13

Showing results (71-80 of 121) with videos related to

Sort By:
Pageof 13
Yonsei Medical Journal|July 13, 2016
Living Donor Liver Transplantation for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis after Concurrent Chemoradiation TherapyDai Hoon Han, Dong Jin Joo, Myoung Soo Kim, et al.
Hepatobiliary Surgery and Nutrition|December 12, 2025
Anatomical complexity of the right-lobe grafts: influence on the outcomes in living donor liver transplantationSeung Hyuk Yim, Incheon Kang, Deok-Gie Kim, et al.
Autophagy|January 9, 2020
SQSTM1/p62 activates NFE2L2/NRF2 via ULK1-mediated autophagic KEAP1 degradation and protects mouse liver from lipotoxicityDa Hyun Lee, Jeong Su Park, Yu Seol Lee, et al.
Journal of Hepatology|May 4, 2020
A nomogram based on liver stiffness predicts postoperative complications in patients with hepatocellular carcinomaMatteo Serenari, Kwang-Hyub Han, Federico Ravaioli, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 3, 2020
Liver-directed combined radiotherapy as a bridge to curative surgery in locally advanced hepatocellular carcinoma beyond the Milan criteriaWon Hee Lee, Hwa Kyung Byun, Jin Sub Choi, et al.
Cancers|November 21, 2020
Hepatocellular Carcinoma Risk According to Regimens for Eradication of Hepatitis C Virus; Interferon or Direct Acting AntiviralsHye Won Lee, Dai Hoon Han, Hye Jung Shin, et al.
Journal of Gastroenterology and Hepatology|March 23, 2013
Prognostic significance of the worst grade in hepatocellular carcinoma with heterogeneous histologic grades of differentiationDai Hoon Han, Gi Hong Choi, Kyung Sik Kim, et al.
Clinical Colorectal Cancer|June 4, 2023
Effect of High-Versus Low-Frequency of Abdominopelvic Computed Tomography Follow-Up Testing on Overall Survival in Patients With Stage II Or III Colon CancerJeongseok Jeon, Da Bin Lee, Sang Joon Shin, et al.
Journal of Hepatology|January 20, 2025
Genomic and transcriptomic signatures of sequential carcinogenesis from papillary neoplasm to biliary tract cancerTaek Chung, Seungho Oh, Jeongsoo Won, et al.
Clinical and Molecular Hepatology|July 23, 2021
Impact of everolimus on survival after liver transplantation for hepatocellular carcinomaIncheon Kang, Jae Geun Lee, Sung Hoon Choi, et al.
Pageof 13